BACKGROUND: The population-based case-control study is not suited to the evaluation of rare genetic (or environmental) factors. The use of a novel case-control design in which cases have second primaries and controls are cancer survivors has been proposed for this purpose. METHODS: We report results from an international study of melanoma that involved population-based ascertainment of incident cases of second or subsequent primary melanoma as the 'case' group and incident cases of first primary melanoma as the 'control' group. We evaluate the validity of the study design by comparing the results obtained for phenotypic factors that have been shown consistently to be associated with melanoma in previous conventional studies with the results from a conventional case-control study conducted in Connecticut and from literature reviews. RESULTS: All but one of the known risk factors for melanoma were shown to be significantly associated with melanoma in our study, though the individual odds ratios appear to be somewhat attenuated relative to the magnitudes typically observed in the literature. CONCLUSIONS: Patients with a second or subsequent primary cancer of a single type represent a potentially valuable and under-utilized resource for the study of cancer aetiology.
BACKGROUND: The population-based case-control study is not suited to the evaluation of rare genetic (or environmental) factors. The use of a novel case-control design in which cases have second primaries and controls are cancer survivors has been proposed for this purpose. METHODS: We report results from an international study of melanoma that involved population-based ascertainment of incident cases of second or subsequent primary melanoma as the 'case' group and incident cases of first primary melanoma as the 'control' group. We evaluate the validity of the study design by comparing the results obtained for phenotypic factors that have been shown consistently to be associated with melanoma in previous conventional studies with the results from a conventional case-control study conducted in Connecticut and from literature reviews. RESULTS: All but one of the known risk factors for melanoma were shown to be significantly associated with melanoma in our study, though the individual odds ratios appear to be somewhat attenuated relative to the magnitudes typically observed in the literature. CONCLUSIONS:Patients with a second or subsequent primary cancer of a single type represent a potentially valuable and under-utilized resource for the study of cancer aetiology.
Authors: Anne Kricker; Bruce K Armstrong; Chris Goumas; Peter Kanetsky; Richard P Gallagher; Colin B Begg; Robert C Millikan; Terence Dwyer; Stefano Rosso; Loraine D Marrett; Nancy E Thomas; Marianne Berwick Journal: Cancer Causes Control Date: 2010-08-19 Impact factor: 2.506
Authors: David C Gibbs; Irene Orlow; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-04-02 Impact factor: 4.254
Authors: Bhramar Mukherjee; John Oliver Delancey; Leon Raskin; Jessica Everett; Joanne Jeter; Colin B Begg; Irene Orlow; Marianne Berwick; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Hoda Anton Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Lynn From; Stephen B Gruber Journal: J Natl Cancer Inst Date: 2012-04-24 Impact factor: 13.506
Authors: Anne Kricker; Bruce K Armstrong; Chris Goumas; Melisa Litchfield; Colin B Begg; Amanda J Hummer; Loraine D Marrett; Beth Theis; Robert C Millikan; Nancy Thomas; Hoda Anton Culver; Richard P Gallagher; Terence Dwyer; Timothy R Rebbeck; Peter A Kanetsky; Klaus Busam; Lynn From; Urvi Mujumdar; Roberto Zanetti; Marianne Berwick Journal: Cancer Causes Control Date: 2007-01-06 Impact factor: 2.506
Authors: Marinela Capanu; Irene Orlow; Marianne Berwick; Amanda J Hummer; Duncan C Thomas; Colin B Begg Journal: Stat Med Date: 2008-05-20 Impact factor: 2.373
Authors: Marianne Berwick; Anne S Reiner; Susan Paine; Bruce K Armstrong; Anne Kricker; Chris Goumas; Anne E Cust; Nancy E Thomas; Pamela A Groben; Lynn From; Klaus Busam; Irene Orlow; Loraine D Marrett; Richard P Gallagher; Stephen B Gruber; Hoda Anton-Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Terry Dwyer; Alison Venn; Julia Lee-Taylor; Colin B Begg Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-07-28 Impact factor: 4.254
Authors: Nancy E Thomas; Sharon N Edmiston; Irene Orlow; Peter A Kanetsky; Li Luo; David C Gibbs; Eloise A Parrish; Honglin Hao; Klaus J Busam; Bruce K Armstrong; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway Journal: J Invest Dermatol Date: 2018-05-09 Impact factor: 8.551
Authors: Urvi J Mujumdar; Jennifer L Hay; Yvette C Monroe-Hinds; Amanda J Hummer; Colin B Begg; Homer B Wilcox; Susan A Oliveria; Marianne Berwick Journal: Psychooncology Date: 2009-10 Impact factor: 3.894